发明名称 |
Systems and methods for determining insulin therapy for a patient |
摘要 |
<p>In example methods and systems described, insulin therapy for a patient can be determined. At least one of a short-acting subcutaneous insulin dosage recommendation, a correction subcutaneous insulin dosage recommendation, an intravenous insulin dosage recommendation, a recommended amount of carbohydrates to be administered to the patient, or combinations thereof, can be determined. In addition, information indicating a confirmation of a nutrition intake for the patient, and a long-acting insulin-on-board for the patient can be received, and based on this information, a required long-acting subcutaneous or intravenous insulin dosage for the patient can be determined. The short-acting subcutaneous or intravenous insulin dosage recommendation can be adjusted based, at least in part, on a difference between the long-acting insulin-on-board and the required long-acting subcutaneous or intravenous insulin dosage.</p> |
申请公布号 |
AU2012358357(A1) |
申请公布日期 |
2014.07.17 |
申请号 |
AU20120358357 |
申请日期 |
2012.12.21 |
申请人 |
MONARCH MEDICAL TECHNOLOGIES, LLC |
发明人 |
RUCHTI, TIMOTHY L.;BURGESS, WILLIAM PATRICK;DUMAS LLL, JOHN;LISIECKI, RONALD;MARTIN, CAROL DIAN;SANTANA, LAURA;THORNLEY, JOHN HARRISON;WATT, JOANNE MARIE |
分类号 |
G06Q50/22 |
主分类号 |
G06Q50/22 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|